Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 24Breast Neoplasms 15Sarcoma 9Myelodysplastic Syndromes 9Carcinoma, Non-Small-Cell Lung 9Stomach Neoplasms 8Multiple Myeloma 7Leukemia, Myelomonocytic, Chronic 7Myeloproliferative Disorders 6Uterine Cervical Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Recurrence 4Prostatic Neoplasms 4Neoplasms 4Melanoma 4Lung Neoplasms 4Leukemia, Monocytic, Acute 4Head and Neck Neoplasms 4Carcinoma, Hepatocellular 4Biliary Tract Neoplasms 4Advanced Solid Tumour 4Stomatitis 3Squamous Cell Carcinoma of Head and Neck 3Ovarian Neoplasms 3Neuroendocrine Tumors 3Mucositis 3Leukemia, Myelomonocytic, Acute 3Esophageal Squamous Cell Carcinoma 3Esophageal Neoplasms 3Cholangiocarcinoma 3

Interventions

Temozolomide 7Radiotherapy 3Everolimus 3nimotuzumab 2Erlotinib Hydrochloride 2Cyclophosphamide 2Bevacizumab 2tovorafenib 1ribociclib 1palbociclib 1olutasidenib 1antineoplaston AS 2-1 1antineoplaston A10 1Vinorelbine 1Valproic Acid 1Topotecan 1TIC10 compound 1Radiation 1Proto-Oncogene Proteins c-akt 1Phosphatidylinositol 3-Kinases 1Panobinostat 1Lomustine 1Irinotecan 1Injections 1GDC-0084 1Etoposide 1Drug Therapy 1Doxorubicin 1Diphtheria-Tetanus Vaccine 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Diffuse Intrinsic Pontine Glioma × Injections × Clear all
NCT07589257 2026-05-15

A Study of VRT106 in Combination With Radiotherapy in Adult Patients With Diffuse Midline Glioma / Diffuse Intrinsic Pontine Glioma

Guangzhou Virotech Pharmaceutical Co., Ltd.

Phase 2 Recruiting
10 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡